Atlas Venture 2024 Year in Review – B. Booth
Atlas Venture partner and LifeSciVC author Bruce Booth shares his 2024 Year in Review. Recorded on November 7, 2024. 00:00 Introduction 01:53 Biopharma Innov…
Atlas Venture partner and LifeSciVC author Bruce Booth shares his 2024 Year in Review. Recorded on November 7, 2024. 00:00 Introduction 01:53 Biopharma Innov…
The United States Department of Agriculture has confirmed the presence of bird flu in Honolulu County, Hawaii, the first of its kind in the state…
This cohort study examines the association of treatment with metformin and add-on antidiabetic medications with asthma attacks.
This economic evaluation illustrates a manufacturer’s estimated spending and revenues as it discontinued a branded product and introduced a generic replacement in response to a…
We’re only going to see more, not fewer, viral outbreaks due to several factors including:-The end of vaccination programs for diseases that have been eradic…
Just discussed data from 2 studies demonstrating efficacy of AI assessment compared to clinician assessment.
Cytisine, a pill that reduces cravings for nicotine, should be considered as a treatment option to help people stop smoking, the National Institute for Health…
Canadian fund Brookfield plans to offer about 7 billion euros ($7.4 billion) for Spanish drugmaker Grifols after finishing due diligence, news website El Confidencial reported…
Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men’s…
In this live, 30-minute certified educational event on posttraumatic stressdisorder (PTSD), an interprofessional panel raises awareness of theimportance of s…
In these updates and new sections, the 2025 GOLD report included highlighted climate change, cardiovascular risk, and pulmonary hypertension.